C9275 HCPCS Level II code: Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose
CMS terminated C9275: its last date of service was Dec 31, 2018. It stays here for looking up older claims; newer services need a current code.
Official description
C9275Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose
Short description: Hexaminolevulinate hcl
HCPCS · United States
Medicare details
The indicators CMS publishes with C9275 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Statute
- Type of service
- Diagnostic radiology
- BETOS category
- Other drugs
- Coverage statute
- 1833(t)
- Cross-reference
- See A9589
- Added
- Jan 1, 2011
- Terminated after
- Dec 31, 2018
Where C9275 sits
- 1C codesOutpatient prospective payment system
- 2Terminated C9275Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code C9275 still valid?
No. CMS terminated C9275; its last date of service was Dec 31, 2018. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover C9275?
CMS lists C9275’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Statute”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside C9275
All C codesC9175Injection, treosulfan, 50 mgC9176Tc-99m from domestically produced non-heu mo-99, [minimum 50 percent], full cost recovery add-on, per study doseC9248Injection, clevidipine butyrate, 1 mgC9250Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 mlC9254Injection, lacosamide, 1 mgC9257Injection, bevacizumab, 0.25 mgC9285Lidocaine 70 mg/tetracaine 70 mg, per patchC9290Injection, bupivacaine liposome, 1 mgC9293Injection, glucarpidase, 10 unitsC9300Injection, indigotindisulfonate sodium, 1 mgC9301Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic doseC9302Injection, zanidatamab-hrii, 2 mg